The BellRing Brands, Inc. (NYSE: BRBR) SEC filings page provides access to the company’s official regulatory documents, as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into BellRing’s operations as a holding company in the global convenient nutrition category, with brands such as Premier Protein, Dymatize and PowerBar.
Through this page, users can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe BellRing’s business, risk factors, financial statements and management’s discussion and analysis. These reports explain how the company’s convenient nutrition products, including ready-to-drink shakes, powders and nutrition bars, contribute to its results within the manufacturing sector.
Current reports on Form 8-K document material events such as new share repurchase authorizations, amendments to the company’s Credit Agreement, earnings releases, director appointments and developments in the Joint Juice litigation. For example, Form 8-K filings detail the approval of a $600 million share repurchase authorization, the increase and extension of the revolving credit facility and the execution of settlement stipulations in class action cases involving Premier Nutrition Company, LLC.
BellRing’s definitive proxy statements (DEF 14A) provide information on corporate governance, board structure, executive compensation, annual meeting agendas and stockholder voting items. These documents outline matters such as the election of directors, ratification of the independent registered public accounting firm and advisory votes on executive pay, as well as policies on director independence, risk oversight and related party transactions.
In addition, insider transaction reports on Form 4, when filed, allow users to track purchases and sales of BellRing common stock by directors and officers, as required under Section 16 of the Exchange Act. Together, these filings form a comprehensive record of BellRing’s regulatory disclosures, capital allocation decisions, governance practices and financial reporting.
Stock Titan enhances this information by pairing real-time EDGAR updates with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand the implications of BellRing’s 10-Ks, 10-Qs, 8-Ks, proxy statements and insider trading reports without reading every page.
BellRing Brands, Inc. reported softer fiscal Q2 2026 results. Net sales rose modestly to $598.7 million, up 2%, but operating profit fell to $66.0 million and net earnings dropped to $33.9 million, down about 42% from a year earlier.
Profitability was pressured by lower average net selling prices for Premier Protein, higher raw material, manufacturing and freight costs, and an $11.3 million inventory charge on a third‑party ingredient that failed quality standards. Higher advertising spending and increased interest expense from greater Revolving Credit Facility borrowings also weighed on results.
For the first six months, net sales grew 1% to $1,136.0 million, while net earnings fell to $77.6 million. Operating cash flow swung to an outflow of $14.3 million due to lower earnings and working capital movements, partly offset by smaller inventory builds and lower tax payments.
BellRing Brands reported weaker second-quarter fiscal 2026 results and cut its full-year outlook. Net sales rose modestly to $598.7 million, up 1.8% year-over-year, but an $11.3 million inventory-related charge, unfavorable price/mix, higher freight and input cost inflation drove gross margin down to 27.0% from 32.3%.
Operating profit fell to $66.0 million and net earnings to $33.9 million, with diluted EPS at $0.29 versus $0.45 a year earlier. Adjusted EBITDA dropped to $53.8 million from $118.6 million. For the first six months, net earnings declined to $77.6 million and operating cash flow turned negative at $(14.3) million.
Management now expects fiscal 2026 net sales of $2.325–$2.365 billion with net sales growth of 0%–2% and Adjusted EBITDA of $315–$335 million, implying an Adjusted EBITDA margin of approximately 14%. The company repurchased 4.2 million shares for $123.1 million in the first half, and category consumption for its Premier Protein and Dymatize brands continued to grow, supported by promotions and distribution gains.
Wasatch Advisors amended its Schedule 13G to report beneficial ownership of 1,994,367 shares of BellRing Brands Inc. That stake represents 1.7% of the outstanding common stock and includes 1,158,341 shares over which Wasatch has sole voting power. The amendment is signed by the filer’s CEO on 04/22/2026.
BELLRING BRANDS, INC. director Robert V. Vitale reported a compensation-related grant of BellRing Brands, Inc. Common Stock equivalents. On March 31, 2026, he acquired 3,625.3500 Common Stock equivalents at a reference value of $16.09 per equivalent, bringing his direct holdings to 9,202.6770 Common Stock equivalents.
These amounts represent the quarterly retainer he earned as a director, which is deferred into Common Stock equivalents under the company’s Deferred Compensation Plan for Directors. The equivalents are credited quarterly and will be distributed on a one-for-one basis in Common Stock when he retires from the board. The Common Stock equivalents have no fixed exercisable or expiration dates.
BELLRING BRANDS, INC. director Chonda J. Nwamu acquired 1,968.047 BellRing Brands, Inc. Common Stock equivalents on March 31, 2026 as a grant/award tied to director compensation. These equivalents were valued at $16.09 each and are credited under the company’s Deferred Compensation Plan for Directors.
The transaction increased Nwamu’s holdings to 11,812.679 Common Stock equivalents. According to the plan, director retainers are deferred into Common Stock equivalents quarterly and will be distributed on a one-for-one basis as BellRing Common Stock upon the director’s retirement from the Board. The Common Stock equivalents have no fixed exercisable or expiration dates.
BELLRING BRANDS, INC. director David Isaiah Finkelstein reported an acquisition of BellRing Brands, Inc. Common Stock equivalents. On March 31, 2026, he received 1,968.0470 Common Stock equivalents as a grant tied to his director retainer under the company’s Deferred Compensation Plan for Directors.
These Common Stock equivalents track the value of BellRing’s Common Stock and will be distributed on a one-for-one basis in actual shares when he retires from the Board of Directors. The filing notes that these equivalents have no fixed exercisable or expiration dates, and his total reported holdings of these equivalents after the transaction are 1,968.0470.
CONWAY SHAWN reported acquisition or exercise transactions in this Form 4 filing.
BELLRING BRANDS, INC. director Shawn Conway reported a routine compensation-related transaction involving deferred stock units. On March 31, 2026, he received a grant of 2,071.627 Common Stock equivalents tied to his board retainer, at a reference price of $16.0900 per equivalent.
These units are credited quarterly under the company’s Deferred Compensation Plan for Directors and represent a right to receive an equal number of BellRing common shares in the future. Following this grant, Conway holds 7,384.833 Common Stock equivalents. The footnotes state these equivalents have no fixed exercisable or expiration dates and will be paid out in common stock on a one-for-one basis when he retires from the board.
JOHNSON JENNIFER KUPERMAN reported acquisition or exercise transactions in this Form 4 filing.
BELLRING BRANDS, INC. director Jennifer Kuperman Johnson received a grant of deferred equity compensation in the form of 1,916.257 Common Stock equivalents on March 31, 2026.
The award was valued at $16.09 per stock equivalent and increased her total balance to 19,520.375 Common Stock equivalents. According to the company’s Deferred Compensation Plan for Directors, these equivalents represent quarterly retainers deferred into stock units and will be paid out one-for-one in BellRing common shares when she retires from the board. The stock equivalents have no fixed exercisable or expiration dates.
STEIN ELLIOT JR reported acquisition or exercise transactions in this Form 4 filing.
BELLRING BRANDS, INC. director Elliot Jr. Stein received a grant of 393.6100 BellRing Brands, Inc. Common Stock equivalents on March 31, 2026. These were credited at a reference price of $16.0900 per share as part of his director retainer.
The award is deferred under the company’s Deferred Compensation Plan for Directors and represents Common Stock equivalents that will be paid out one-for-one in BellRing Brands common stock when he retires from the Board. Following this grant, Stein holds a total of 2,415.1380 Common Stock equivalents, which have no fixed exercisable or expiration dates.
ERICKSON THOMAS P reported acquisition or exercise transactions in this Form 4 filing.
BELLRING BRANDS, INC. director Thomas P. Erickson received a grant of 2,952.069 BellRing Brands, Inc. Common Stock Equivalents on March 31, 2026 as part of his director compensation. These units were valued at $16.09 per equivalent and are credited under the company’s Deferred Compensation Plan for Directors.
Following this grant, Erickson holds a total of 24,921.101 Common Stock Equivalents directly. The footnotes explain that his director retainer is deferred quarterly into these stock equivalents and that, upon his retirement from the Board, the value is paid out in BellRing common shares on a one-for-one basis. The Common Stock Equivalents have no fixed exercisable or expiration dates, emphasizing their nature as deferred compensation rather than short-term trading instruments.